1. Introduction to HSCT for neurologic diseases 2. Modification of T and B cell-associated immuno-pathological mechanisms in multiple sclerosis by 3. The hematopoietic niche and the autoreactive memory in autoimmune disorders 4. The preclinical data and immunological rationale for haematopoietic stem cell transplantation in 5. Immune cell reconstitution following autologous haematopoietic stem cell transplantation in multiple sclerosis 6. Immune reconstitution in rheumatic disease patients after autologous hematopoietic stem cell transplantation 7. The role of chemotherapy in hematopoietic stem cell transplantation HSCT for autoimmune disorders: from lymphoablative to myeloablative conditioning protocols 8.

The HSCT procedure (I): mobilization, collection, manipulation and cryopreservation of HSC 9. The HSCT procedure (II): conditioning, hemopoietic stem cell infusion, supportive care and monitoring 10. Early and late complications of HSCT 11. Hematopoietic Stem Cell Transplantation for Multiple Sclerosis 12. Hematopoietic stem cell transplantation for neuromyelitis optica spectrum disorder. Can immune tolerance be re-established? 13. Hematopoietic stem cell transplantation (HSCT) for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): Is it CIDP? 14. HSCT for Stiff Person Syndrome and Myasthenia Gravis 15.

Autologous hematopoietic stem cell transplantation for pediatric autoimmune neurologic disorders 16. HSCT for systemic autoimmune diseases with neurologic involvement 17. Hematopoetic Stem Cell Therapy and Ex Vivo Gene Therapy for X-linked Adrenoleukodystrophy 18. Economics of Hematopoietic Stem Cell Transplant in immune-mediated neurologic autoimmune diseases 19. The EBMT-ADWP and the CIBMTR 20. Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis: StarMS.